Nusrath Fathima1, Parimala Narne2, Mohammed Ishaq3,4. 1. Department of Genetics, Osmania University, Hyderabad, Telangana, India. 2. Department of Biotechnology and Bioinformatics, University of Hyderabad, Hyderabad, Telangana, India. parimala_narne@yahoo.co.in. 3. Department of Genetics, Osmania University, Hyderabad, Telangana, India. ishaq_50@rediffmail.com. 4. Salar-E-Millat, Research Centre for Cellular and Molecular Medicine, Princess Esra Hospital, Deccan College of Medical Sciences, Hyderabad, Telangana, India. ishaq_50@rediffmail.com.
Abstract
PURPOSE: Polymorphic variants of cytotoxic T-lymphocyte antigen-4 (CTLA-4) and forkhead box protein P3 (FOXP3) genes are implicated in dysregulated immune homeostasis and autoimmune disorders. We analyzed the association between CTLA-4 rs231775 and FOXP3 rs3761548, rs3761549 polymorphisms and predisposition to autoimmune thyroid disease (AITD), inclusive of Hashimoto's thyroiditis (HT) and Graves' disease (GD) in South-Indian population. METHODS: A total of 355 AITD subjects (comprising 275 HT and 80 GD) and 285 randomly selected age- and sex-matched control subjects were genotyped for the aforementioned polymorphisms by PCR-RFLP method. RESULTS: The rs231775 "G" allele was preponderant in HT and GD subjects when compared with controls and exerted a dominant influence on the susceptibility to HT (p = 0.009) and GD (p = 0.02), respectively. There was no allelic association of rs3761548 and rs3761549 polymorphisms with AITD susceptibility, albeit a significant difference in genotype distribution with respect to rs3761549. Haplotype analysis revealed an increased frequency of rs3761548 "C"-rs3761549 "T" in HT and GD subjects, thereby associating it with disease predisposition (p = 0.03). Epistatic interaction analysis by multifactor dimensionality reduction approach revealed redundancy between CTLA-4 and FOXP3 genes in influencing the susceptibility to AITD. CONCLUSIONS: The genetic variation in CTLA-4 gene with reference to rs231775 polymorphism contributes to an increased predisposition to HT and GD. Also, in conjunction with FOXP3 gene variants it seems to influence the susceptibility to HT and GD respectively. The significance of these findings in combination with antithyroid antibody screening could plausibly contribute towards meticulous case-finding for effective treatment of HT and GD.
PURPOSE: Polymorphic variants of cytotoxic T-lymphocyte antigen-4 (CTLA-4) and forkhead box protein P3 (FOXP3) genes are implicated in dysregulated immune homeostasis and autoimmune disorders. We analyzed the association between CTLA-4rs231775 and FOXP3rs3761548, rs3761549 polymorphisms and predisposition to autoimmune thyroid disease (AITD), inclusive of Hashimoto's thyroiditis (HT) and Graves' disease (GD) in South-Indian population. METHODS: A total of 355 AITD subjects (comprising 275 HT and 80 GD) and 285 randomly selected age- and sex-matched control subjects were genotyped for the aforementioned polymorphisms by PCR-RFLP method. RESULTS: The rs231775 "G" allele was preponderant in HT and GD subjects when compared with controls and exerted a dominant influence on the susceptibility to HT (p = 0.009) and GD (p = 0.02), respectively. There was no allelic association of rs3761548 and rs3761549 polymorphisms with AITD susceptibility, albeit a significant difference in genotype distribution with respect to rs3761549. Haplotype analysis revealed an increased frequency of rs3761548 "C"-rs3761549 "T" in HT and GD subjects, thereby associating it with disease predisposition (p = 0.03). Epistatic interaction analysis by multifactor dimensionality reduction approach revealed redundancy between CTLA-4 and FOXP3 genes in influencing the susceptibility to AITD. CONCLUSIONS: The genetic variation in CTLA-4 gene with reference to rs231775 polymorphism contributes to an increased predisposition to HT and GD. Also, in conjunction with FOXP3 gene variants it seems to influence the susceptibility to HT and GD respectively. The significance of these findings in combination with antithyroid antibody screening could plausibly contribute towards meticulous case-finding for effective treatment of HT and GD.
Authors: Helga Schneider; Jos Downey; Andrew Smith; Bernd H Zinselmeyer; Catherine Rush; James M Brewer; Bin Wei; Nancy Hogg; Paul Garside; Christopher E Rudd Journal: Science Date: 2006-08-24 Impact factor: 47.728
Authors: Artur Bossowski; Hanna Borysewicz-Sańczyk; Natalia Wawrusiewicz-Kurylonek; Aneta Zasim; Mieczysław Szalecki; Beata Wikiera; Ewa Barg; Małgorzata Myśliwiec; Anna Kucharska; Anna Bossowska; Joanna Gościk; Katarzyna Ziora; Maria Górska; Adam Krętowski Journal: Autoimmunity Date: 2014-05-01 Impact factor: 2.815
Authors: H Donner; H Rau; P G Walfish; J Braun; T Siegmund; R Finke; J Herwig; K H Usadel; K Badenhoop Journal: J Clin Endocrinol Metab Date: 1997-01 Impact factor: 5.958
Authors: T Awata; S Kurihara; M Iitaka; S Takei; I Inoue; C Ishii; K Negishi; T Izumida; Y Yoshida; R Hagura; N Kuzuya; Y Kanazawa; S Katayama Journal: Diabetes Date: 1998-01 Impact factor: 9.461
Authors: Edyta Pawlak-Adamska; Irena Frydecka; Marek Bolanowski; Anna Tomkiewicz; Anna Jonkisz; Lidia Karabon; Anna Partyka; Oskar Nowak; Marek Szalinski; Jacek Daroszewski Journal: Endocrine Date: 2016-09-16 Impact factor: 3.633
Authors: Damilola Oyewole-Said; Vanaja Konduri; Jonathan Vazquez-Perez; Scott A Weldon; Jonathan M Levitt; William K Decker Journal: Front Immunol Date: 2020-12-15 Impact factor: 7.561